Allurion Technologies (ALURW) Consolidated Net Income (2022 - 2026)
Allurion Technologies (ALURW) reported Consolidated Net Income of -$6.1 million for Q1 2026, down 306.06% on a YoY basis from $3.0 million in Q1 2025, and down 126.48% quarter-over-quarter from $23.0 million in Q4 2025.
Allurion Technologies (ALURW) Consolidated Net Income (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Consolidated Net Income for 5 years, with the latest figure at -$6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income fell 306.06% year-over-year to -$6.1 million; the trailing twelve-month figure through Mar 2026 stood at -$4.3 million (down 24.5% YoY), and the FY2025 full-year result was $347000.0, up 179.84% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$6.1 million, down from $23.0 million in the prior quarter.
- The five-year high for Consolidated Net Income was $62.0 million in Q4 2023, with the low at -$22.0 million in Q2 2023.
- Historically, Consolidated Net Income has averaged $115875.0 across 5 years, with a median of -$5.8 million in 2022.
- Annual changes were most pronounced in 2023 — Consolidated Net Income sank 306.96% — and 2025, when it surged 1102.61%.
- Allurion Technologies' Consolidated Net Income stood at $26.0 million in 2022, then soared by 138.98% to $62.0 million in 2023, then tumbled by 103.7% to -$2.3 million in 2024, then surged by 1102.61% to $23.0 million in 2025, then tumbled by 126.48% to -$6.1 million in 2026.
- The last three Consolidated Net Income figures came in at -$6.1 million (Q1 2026), $23.0 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 62.04 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | 25.96 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |